Synergy CHC Corp, a provider of consumer health care and lifestyle products, reported its financial results for the first quarter of 2025, highlighting a 30% year-over-year growth in earnings per share to $0.10 from $0.08. The company noted a decrease in revenue, which was $8.2 million compared to $9.4 million in the same period of the previous year. Despite the decline in revenue, Synergy experienced an increase in net income, which rose to $876.3 thousand from $580.5 thousand, marking a 51% improvement. The company's EBITDA for the first quarter was $1.98 million, up 7% from $1.85 million in the prior year period, attributed primarily to lower selling, general, and administrative expenses. Synergy also reported a significant expansion in its gross margin, which increased to 75.4% from 72.0%. As of March 31, 2025, the company's inventory amounted to $2.3 million, up from $1.7 million at the end of December 2024. Cash used in operating activities was $822.8 thousand for the quarter, slightly lower than the $858 thousand used in the same period of the previous year. Additionally, Synergy reduced its total liabilities to $31.3 million from $33.0 million as of December 31, 2024, reflecting an improvement of $1.7 million. Synergy's CEO, Jack Ross, emphasized the company's ongoing profitability and expanded EBITDA margins, stating that these results underscore the strength of their operating model and cost management discipline. The company remains focused on its strategic goals and growth initiatives for 2025, maintaining confidence in its ability to drive sustainable growth and shareholder value.